81907-62-2
81907-62-2 結(jié)構(gòu)式
基本信息
靈芝酸A對(duì)照品,
靈芝酸A(標(biāo)準(zhǔn)品)
靈芝酸A(95%)
靈芝酸 A(96%)
靈芝酸 A, 來源于靈芝
靈芝酸 A?, >98%
靈芝酸AGANODERIC ACID A
GANODERENIC ACID A 靈芝酸A
JAK-STAT3信號(hào)通路抑制劑(GANODERIC ACID A)
Aids070759
Aids-070759
GANODERIC ACID A
GANODERIC ACID A(P)
Ganoderic acid A, >98%
-6-((7S,10S,13R,14R,15S,17R)
-2-methyl-4-oxoheptanoic acid
Ganoderic acid A, froM GanoderMa luciduM
(25R)-7β,15α-Dihydroxy-3,11,23-trioxo-5α-lanost-8-en-26-oicaci
物理化學(xué)性質(zhì)
應(yīng)用領(lǐng)域
藥理藥效:抑制細(xì)胞組織胺的釋放，增強(qiáng)消化系統(tǒng)各種器官的機(jī)能，具有降血脂、降血壓、護(hù)肝、調(diào)節(jié)肝功能等作用。
| 報(bào)價(jià)日期 | 產(chǎn)品編號(hào) | 產(chǎn)品名稱 | CAS號(hào) | 包裝 | 價(jià)格 |
| 2024/08/19 | HY-N1447 | 靈芝酸A Ganoderic acid A | 81907-62-2 | 1mg | 500元 |
| 2024/08/19 | HY-N1447 | 靈芝酸A Ganoderic acid A | 81907-62-2 | 5mg | 1250元 |
| 2024/08/19 | HY-N1447 | 靈芝酸A Ganoderic acid A | 81907-62-2 | 10mM * 1mLin DMSO | 1380元 |
常見問題列表
|
Human Endogenous Metabolite
|
A lower doses of Ganoderic acid A enhance HLA class II-mediated antigen presentation and CD4+ T cell recognition of lymphoma.
Ganoderic acid A promots cisplatin-induced cell death by enhancing the sensitivity of HepG2 cells to cisplatin mainly via the signal transducer and activator of transcription 3 suppression.
Ganoderic acid Ainhibits proliferation, viability, ROS, DPPH, and analyzed the expression of SOD1, SOD2, and SOD3 by Real time PCR in a PC-3 cell in a dose-dependent manner.
Ganoderic acid A effectively inhibites the proliferation of human osteosarcoma HOS and MG-63 cells in a dose-dependent manner, and induced obvious cell apoptosis in both cells.
Ganoderic acid A treatment significantly prolonged survival of EL4 challenged mice and decreased tumor metastasis to the liver.